Project Details
| Short title | SHR-4602-102 |
|---|---|
| Status | Finished |
| Effective start/end date | 7/11/24 → 26/02/25 |
CTU: An Open-Label, Multi-Center Phase 1 Dose-Expansion Study to Evaluate The Safety, Tolerability, Pharmacokinetics, and Efficacy of SHR-4602 In Subjects With HER2-Expressing or HER2-Mutated Locally Advanced or Metastatic Solid Tumors
- Park, John (Primary Chief Investigator)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- McHugh, Tracey (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
Project: Research